Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

57.63 -0.73 (-1.25%)

Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3,245,221
Open	58.36
Bid (Size)	57.22 (100)
Ask (Size)	59.50 (1,500)
Prev. Close	58.36
Today's Range	57.22 - 58.40
52wk Range	34.96 - 64.38
Shares Outstanding	388,132,400
Dividend Yield	1.63%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? ↗

Today 12:50 EDT

Investors are catching on to this rare gem among pharmaceutical stocks, but thanks to promising growth and a low valuation, further upside remains.

Via The Motley Fool

Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts ↗

September 25, 2026

Royalty Pharma (NASDAQ:RPRX) executives said the company is monitoring a shifting biopharma policy environment, expanding its artificial-intelligence capabilities and building a presence in China,...

Via MarketBeat

Performance

YTD	+48.3%	+48.3%
1 Month	-6.2%	-6.2%
3 Month	+3.3%	+3.3%
6 Month	+18.8%	+18.8%
1 Year	+63.4%	+63.4%

More News

Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? ↗

September 24, 2026

Via The Motley Fool

Royalty Pharma (NASDAQ:RPRX) Hits Perfect Technical Rating with Breakout Setup ↗

August 13, 2026

Via Chartmill

Royalty Pharma (NASDAQ:RPRX) Beats Q2 Revenue Estimates, Raises Full-Year Guidance ↗

August 05, 2026

Via Chartmill

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program

September 15, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma to present at upcoming investor conferences

September 09, 2026

From Royalty Pharma plc

Via GlobeNewswire

If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today ↗

September 08, 2026

Via Benzinga

Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen

September 04, 2026

From Royalty Pharma plc

Via GlobeNewswire

If You Invested $1000 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today ↗

August 21, 2026

Via Benzinga

Here’s How Much You Would Have Made Owning Royalty Pharma Stock In The Last 10 Years ↗

August 14, 2026

Via Benzinga

Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million

August 12, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Via The Motley Fool

Royalty Pharma Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

Royalty Pharma reports second quarter 2026 results

August 05, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives

August 03, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune

July 22, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma declares third quarter 2026 dividend

July 17, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026

July 15, 2026

From Royalty Pharma plc

Via GlobeNewswire

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

June 14, 2026

Via StockStory

3 Unpopular Stocks We’re Skeptical Of

June 12, 2026

Via StockStory

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings?

June 09, 2026

Via StockStory

Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference

June 04, 2026

From Royalty Pharma plc

Via GlobeNewswire

Mattel Stock Is Down 24%. Here's What a $50.9 Million Exit Could Mean ↗

May 29, 2026

Via The Motley Fool

Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 13, 2026

Via StockStory

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?

Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.

What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?

Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?

The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market

What is the current price of Royalty Pharma plc - Class A Ordinary Shares?

The current price of Royalty Pharma plc - Class A Ordinary Shares is 57.63

When was Royalty Pharma plc - Class A Ordinary Shares last traded?

The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 10/01/26 04:00 PM ET

What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?

The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 22.37B

How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?

Royalty Pharma plc - Class A Ordinary Shares has 22B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.